Chargement en cours...
Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial
OBJECTIVE: To determine whether treatment with recombinant human thrombomodulin (rhTM) increases survival among patients with severe septic-induced disseminated intravascular coagulation (DIC). DESIGN: Single-centre, open-label, randomised controlled trial. SETTING: Single tertiary hospital. PARTICI...
Enregistré dans:
| Publié dans: | BMJ Open |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Publishing Group
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5223629/ https://ncbi.nlm.nih.gov/pubmed/28039291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2016-012850 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|